Prospects for antidepressant drug discovery

Biological Psychology

Volumn 57, Issue 1-3, 2001, Pages 47-65

  Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Depression; Neuropeptides; Neurotransmitter; Pharmacology; Receptors

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; ANTIDEPRESSANT AGENT; CORTICOSTEROID RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; HYDROCORTISONE; IMIPRAMINE; ISONIAZID; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ALCOHOLISM; ANIMAL MODEL; ANXIETY; AUTOMUTILATION; BATTLE INJURY; BIOTECHNOLOGY; CANCER; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEMENTIA; DEPRESSION; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG TARGETING; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTHESIS; LOWER RESPIRATORY TRACT INFECTION; MOUSE MUTANT; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; STRESS; TRAFFIC ACCIDENT; TUBERCULOSIS;

EID: 0034938923     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0511(01)00089-8     Document Type: Article

References (45)

1. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
2. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
3. Depression and the course of coronary disease
4. The combined dexamethasone-/CRH test: a refined laboratory test for psychiatric disorders
5. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and in normal comparison subjects
6. Molekulare Mechanismen der Depressionstherapie
7. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
8. The corticosteroid receptor hypothesis of depression
9. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
10. Altered hypothalamic pituitary-adrenocortical regulation in healthy subjects at high familial risk for depression
11. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment - neurobiological and psychometric assessemtn of course
12. Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning
13. The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats
14. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorder in the United States
15. Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
16. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats
17. Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour
18. 2 receptor antisense oligonucleotides into the rat brain
19. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral and cytokine responses to a systemic inflammatory challenge
20. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications
21. Corticosteroid receptor function is decreased in depressed patients
22. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study
23. Increased number of vasopressin and oxytocin expressing neurons in the paraventricular nucleus of the human hypothalamus in depression
24. Validity of clinical trials of antidepressants
25. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
26. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
27. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide
28. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness
29. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription
30. Health care costs associated with depressive and anxiety disorder in primary care
31. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat
32. Corticotropin-releasing hormone recptor (type 1) antisense targeting reduces anxiety
33. Corticotropin-releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
34. Corticotropin-releasing hormone receptor subtypes and emotion
35. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior
36. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment
37. Current issues in the economics of depression management
38. Impaired stress response and reduced anxiety in mice lacking a functional corticostropin-releasing hormone receptor 1
39. Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr1a P-glycoprotein gene discruption
40. Cortisol response to a combined dexamethasone-h-CRH challenge in patients with depression
41. Prediction of medium-term outcome to the combined dexamethasone-CRH test test in patients with remitted depression
42. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated